All stock lists
Pulmonx Corp (LUNG)
United States · Delayed Price · Currency is USD
Surgical & Medical Instruments & Apparatus
1.87+0.04 (+2.19%)
Insider Score
––Not scored
LUNG Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
LUNG Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 22.76 M | 20.59 M | 22.60 M | 21.50 M | 23.86 M |
| Revenue Growth (YoY) | -4.62 % | — | — | — | — |
| Cost of Revenue | 5.01 M | 4.54 M | 5.06 M | 5.45 M | 6.66 M |
| Gross Profit | 17.74 M | 16.04 M | 17.54 M | 16.05 M | 17.20 M |
| SG&A Expense | 21.77 M | 24.10 M | 22.86 M | 25.60 M | 26.70 M |
| R&D Expense | 5.03 M | 4.90 M | 4.58 M | 4.85 M | 5.31 M |
| Operating Expenses | 26.80 M | 29.00 M | 27.44 M | 30.45 M | 32.01 M |
| Operating Income | -9.06 M | -12.96 M | -9.90 M | -14.39 M | -14.80 M |
| Pretax Income | -9.95 M | -13.51 M | -10.24 M | -13.83 M | -15.00 M |
| Tax Provision | 133.00 K | 149.00 K | 186.00 K | 128.00 K | 177.00 K |
| Net Income | -10.08 M | -13.65 M | -10.43 M | -13.96 M | -15.17 M |
| EPS (Basic) | -0.24 | -0.33 | -0.25 | -0.34 | -0.38 |
| EPS (Diluted) | -0.24 | -0.33 | -0.25 | -0.34 | -0.38 |
| Shares Outstanding | 42.47 M | 41.90 M | 41.40 M | 40.94 M | 40.43 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.